3009 boulevard de la Concorde East
Laval, QC H7E 2B5
Full Time Employees:
|Ms. Janelle D'Alvise||Pres, CEO, Corp. Sec. & Director||428.04k||N/A||1956|
|Dr. Pierre Lemieux M.D., Ph.D.||Co-Founder, COO & Chief Scientific Officer||276.38k||N/A||1965|
|Mr. Brian D. Ford CPA, CA||Chief Financial Officer||364.82k||N/A||1959|
|Dr. Yves Lachance Ph.D.||VP of Quality & Compliance||N/A||N/A||N/A|
|Dr. George Kottayil||Chief Operating Officer of US||N/A||N/A||N/A|
|Mr. Prashant Kohli||VP of Commercial Operations||N/A||N/A||N/A|
Acasti Pharma Inc., a biopharmaceutical company, engages in the development and commercialization of pharmaceutical products for cardiovascular diseases. It is evaluating strategic partnerships for the clinical development of CaPre, an omega-3 phospholipid therapeutic to treat patients with hypertriglyceridemia. The company was incorporated in 2002 and is headquartered in Laval, Canada.
Acasti Pharma Inc.’s ISS Governance QualityScore as of N/A is N/A. The pillar scores are Audit: N/A; Board: N/A; Shareholder Rights: N/A; Compensation: N/A.